Shaban Haitham A, Gasser Susan M
Precision Oncology Center, Department of Oncology, Lausanne University Hospital, 1005, Lausanne, Switzerland.
Agora Cancer Research Center Lausanne, Rue du Bugnon 25A, 1005, Lausanne, Switzerland.
Cell Death Differ. 2025 Jan;32(1):9-15. doi: 10.1038/s41418-023-01197-y. Epub 2023 Aug 18.
Cellular senescence, a cell state characterized by growth arrest and insensitivity to growth stimulatory hormones, is accompanied by a massive change in chromatin organization. Senescence can be induced by a range of physiological signals and pathological stresses and was originally thought to be an irreversible state, implicated in normal development, wound healing, tumor suppression and aging. Recently cellular senescence was shown to be reversible in some cases, with exit being triggered by the modulation of the cell's transcriptional program by the four Yamanaka factors, the suppression of p53 or H3K9me3, PDK1, and/or depletion of AP-1. Coincident with senescence reversal are changes in chromatin organization, most notably the loss of senescence-associated heterochromatin foci (SAHF) found in oncogene-induced senescence. In addition to fixed-cell imaging, chromatin conformation capture and multi-omics have been used to examine chromatin reorganization at different spatial resolutions during senescence. They identify determinants of SAHF formation and other key features that differentiate distinct types of senescence. Not surprisingly, multiple factors, including the time of induction, the type of stress experienced, and the type of cell involved, influence the global reorganization of chromatin in senescence. Here we discuss how changes in the three-dimensional organization of the genome contribute to the regulation of transcription at different stages of senescence. In particular, the distinct contributions of heterochromatin- and lamina-mediated interactions, changes in gene expression, and other cellular control mechanisms are discussed. We propose that high-resolution temporal and spatial analyses of the chromatin landscape during senescence will identify early markers of the different senescence states to help guide clinical diagnosis.
细胞衰老,一种以生长停滞和对生长刺激激素不敏感为特征的细胞状态,伴随着染色质组织的巨大变化。衰老可由一系列生理信号和病理应激诱导,最初被认为是一种不可逆的状态,与正常发育、伤口愈合、肿瘤抑制和衰老有关。最近发现,细胞衰老在某些情况下是可逆的,其退出是由四个山中因子对细胞转录程序的调节、p53或H3K9me3的抑制、PDK1和/或AP-1的消耗所触发的。与衰老逆转同时发生的是染色质组织的变化,最显著的是在癌基因诱导的衰老中发现的衰老相关异染色质灶(SAHF)的丧失。除了固定细胞成像外,染色质构象捕获和多组学已被用于研究衰老过程中不同空间分辨率下的染色质重组。它们确定了SAHF形成的决定因素以及区分不同类型衰老的其他关键特征。不出所料,多种因素,包括诱导时间、所经历的应激类型和所涉及的细胞类型,都会影响衰老过程中染色质的全局重组。在这里,我们讨论基因组三维组织的变化如何在衰老的不同阶段促进转录调控。特别是,讨论了异染色质和核纤层介导的相互作用、基因表达变化和其他细胞控制机制的不同贡献。我们提出,对衰老过程中染色质景观进行高分辨率的时空分析将识别不同衰老状态的早期标志物,以帮助指导临床诊断。